![Summer Experience Programs](../../assets/md5images/ffdf193ce8ff01e41842b4d5e32f9eb7.jpg)
Files
Download
Download Full Text (867 KB)
DOI
https://doi.org/10.52519/00018
Keywords
Olaparib, Neoadjuvant, BRCA Mutation
Program Affiliation
Partnership for Careers in Cancer Science and Medicine
Recommended Citation
Michael, Victoria; Westin, Shannon N.; Onstad-Grinsfelder, Michaela; Meyer, Larissa A.; Fleming, Nicole; and Yuan, Yin, "Feasibility Study of Neoadjuvant Olaparib for Frontline BRCA Mutant Ovarian Cancer" (2022). Summer Experience 2022. 93.
doi:https://doi.org/10.52519/00018
![Feasibility Study of Neoadjuvant Olaparib for Frontline BRCA Mutant Ovarian Cancer](https://openworks.mdanderson.org/sumexp22/1095/thumbnail.jpg)